The management of COPD in Greece is associated with intensive resource use and significant economic burden. Exacerbations and productivity losses are the key cost drivers. Cost containment policies should focus on prioritizing treatments that increase patient compliance as these can lead to reduction of exacerbations, longer maintenance phases, and thus lower costs.
No takes yet. Share an insight, caveat, or question.
Souliotis et al. (2017) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: